Von Wronski; Mathew A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Von Wronski; Mathew A..The latest application filed is for "multivalent constructs for therapeutic and diagnostic applications".

Company Profile

0.19.20

Von Wronski; Mathew A. - Geneva CH
Von Wronski; Mathew A. - Moorestown NJ
Von Wronski; Mathew A. - Morrestown NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,446,155 - Sato , et al. September 20, 2	2016-09-20
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,408,926 - Arbogast , et al. August 9, 2	2016-08-09
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20150374843 - Fan; Hong ; et al.	2015-12-31
Multivalent constructs for therapeutic and diagnostic applications Grant 9,056,138 - Fan , et al. June 16, 2	2015-06-16
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140286864 - SATO; AARON K. ; et al.	2014-09-25
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20140205545 - FAN; Hong ; et al.	2014-07-24
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140161732 - ARBOGAST; Christophe ; et al.	2014-06-12
Multivalent constructs for therapeutic and diagnostic applications Grant 8,663,603 - Arbogast , et al. March 4, 2	2014-03-04
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,642,010 - Sato , et al. February 4, 2	2014-02-04
Multivalent constructs for therapeutic and diagnostic applications Grant 8,632,753 - Fan , et al. January 21, 2	2014-01-21
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,623,822 - Arbogast , et al. January 7, 2	2014-01-07
Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use App 20120315220 - Von Wronski; Mathew A. ; et al.	2012-12-13
Compounds for targeting endothelial cells, compositions containing the same and methods for their use Grant 8,263,739 - Von Wronski , et al. September 11, 2	2012-09-11
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20110286929 - Fan; Hong ; et al.	2011-11-24
Compounds For Targeting Endothelial Cells, Compositions Containing The Same And Methods For Their Use App 20110262366 - Von Wronski; Mathew A. ; et al.	2011-10-27
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20110097275 - Arbogast; Christophe ; et al.	2011-04-28
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20110070165 - Arbogast; Christophe ; et al.	2011-03-24
Multivalent constructs for therapeutic and diagnostic applications Grant 7,910,088 - Arbogast , et al. March 22, 2	2011-03-22
Compounds for targeting endothelial cells, compositions containing the same and methods for their use Grant 7,884,183 - Von Wronski , et al. February 8, 2	2011-02-08
Multivalent constructs for therapeutic and diagnostic applications Grant 7,854,919 - Arbogast , et al. December 21, 2	2010-12-21
Compounds for targeting endothelial cells, compositions containing the same and methods for their use Grant 7,820,621 - Von Wronski , et al. October 26, 2	2010-10-26
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20100003195 - Sato; Aaron K. ; et al.	2010-01-07
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070243139 - Arbogast; Christophe ; et al.	2007-10-18
Multivalent constructs for therapeutic and diagnostic applications Grant 7,261,876 - Arbogast , et al. August 28, 2	2007-08-28
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070172428 - Arbogast; Christophe ; et al.	2007-07-26
Multivalent constructs for therapeutic and diagnostic applications Grant 7,211,240 - Arbogast , et al. May 1, 2	2007-05-01
Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use App 20060263303 - Von Wronski; Mathew A. ; et al.	2006-11-23
Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use App 20060258566 - Von Wronski; Mathew A. ; et al.	2006-11-16
Compounds for targeting endothelial cells, compositions containing the same and methods for their use Grant 7,109,167 - Von Wronski , et al. September 19, 2	2006-09-19
Compounds for targeting endothelial cells, compositions containing the same and methods for their use App 20060153775 - Von Wronski; Mathew A. ; et al.	2006-07-13
KDR and VEGF/KDR binding peptides App 20050250700 - Sato, Aaron K. ; et al.	2005-11-10
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy App 20050100963 - Sato, Aaron K. ; et al.	2005-05-12
Multivalent constructs for therapeutic and diagnostic applications App 20050027105 - Arbogast, Christophe ; et al.	2005-02-03
Multivalent constructs for therapeutic and diagnostic applications App 20040210041 - Arbogast, Christophe ; et al.	2004-10-21
Compounds for targeting endothelial cells, compositions containing the same and methods for their use App 20020147136 - Von Wronski, Mathew A. ; et al.	2002-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.